Masimo reported $478.9 million in revenue for the quarter ended September 2023, representing a year-over-year decline of 12.8%. EPS of $0.63 for the same period compares to $1.00 a year ago.
The reported revenue represents a surprise of -4.67% over the Zacks Consensus Estimate of $502.38 million. With the consensus EPS estimate being $0.59, the EPS surprise was +6.78%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Masimo performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Non-healthcare: $171.10 million compared to the $177.04 million average estimate based on two analysts.
- Revenue- Healthcare: $307.80 million compared to the $329.11 million average estimate based on two analysts.
- Gross Profit- Non-healthcare: $55.80 million versus the two-analyst average estimate of $60.14 million.
- Gross Profit- Healthcare: $185.60 million versus $194.26 million estimated by two analysts on average.
View all Key Company Metrics for Masimo here>>>Shares of Masimo have returned -2.8% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
View the Zacks #1 Rank List
Image: Bigstock
Compared to Estimates, Masimo (MASI) Q3 Earnings: A Look at Key Metrics
Masimo reported $478.9 million in revenue for the quarter ended September 2023, representing a year-over-year decline of 12.8%. EPS of $0.63 for the same period compares to $1.00 a year ago.
The reported revenue represents a surprise of -4.67% over the Zacks Consensus Estimate of $502.38 million. With the consensus EPS estimate being $0.59, the EPS surprise was +6.78%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Masimo performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Non-healthcare: $171.10 million compared to the $177.04 million average estimate based on two analysts.
- Revenue- Healthcare: $307.80 million compared to the $329.11 million average estimate based on two analysts.
- Gross Profit- Non-healthcare: $55.80 million versus the two-analyst average estimate of $60.14 million.
- Gross Profit- Healthcare: $185.60 million versus $194.26 million estimated by two analysts on average.
View all Key Company Metrics for Masimo here>>>Shares of Masimo have returned -2.8% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.